TRIDENTE, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 4.284
EU - Europa 3.593
AS - Asia 1.251
SA - Sud America 13
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 9.156
Nazione #
US - Stati Uniti d'America 4.272
GB - Regno Unito 1.683
CN - Cina 948
SE - Svezia 371
FR - Francia 276
IE - Irlanda 274
FI - Finlandia 269
DE - Germania 231
SG - Singapore 202
RU - Federazione Russa 182
IT - Italia 119
UA - Ucraina 95
BE - Belgio 27
TR - Turchia 25
NL - Olanda 19
IR - Iran 14
VN - Vietnam 11
ES - Italia 10
CA - Canada 9
IL - Israele 9
IN - India 9
KR - Corea 8
BR - Brasile 6
PL - Polonia 6
ID - Indonesia 5
JP - Giappone 5
PH - Filippine 5
AU - Australia 4
CH - Svizzera 4
NO - Norvegia 4
PT - Portogallo 4
AT - Austria 3
CL - Cile 3
CZ - Repubblica Ceca 3
EU - Europa 3
LV - Lettonia 3
MA - Marocco 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
EG - Egitto 2
LT - Lituania 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BD - Bangladesh 1
BS - Bahamas 1
DK - Danimarca 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
KZ - Kazakistan 1
LU - Lussemburgo 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
RO - Romania 1
SA - Arabia Saudita 1
SC - Seychelles 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 9.156
Città #
Southend 1.505
Jacksonville 932
Chandler 661
Woodbridge 606
Ann Arbor 379
Dublin 274
Ashburn 266
Houston 216
Singapore 140
Wilmington 136
Beijing 123
Jinan 123
Lawrence 111
Princeton 111
Nanjing 101
Shenyang 87
New York 84
Hebei 69
Verona 66
Helsinki 56
Lancaster 50
Nanchang 41
Changsha 38
Boardman 36
Tianjin 36
Haikou 34
Zhengzhou 33
Sindelfingen 29
Brussels 27
Hangzhou 27
Jiaxing 27
Ningbo 26
Seattle 25
Taiyuan 24
Taizhou 24
Guangzhou 23
Milan 22
Fairfield 21
Norwalk 18
Dearborn 17
Philadelphia 17
Falls Church 16
Cambridge 15
Dallas 15
Lanzhou 14
Los Angeles 14
Fuzhou 13
Chicago 11
Dong Ket 9
Nürnberg 9
Redwood City 9
San Mateo 9
Auburn Hills 8
Detroit 8
Düsseldorf 8
Seoul 8
Washington 8
Munich 7
Dongguan 6
Edinburgh 5
Kent 5
San Francisco 5
Zanjan 5
Clearwater 4
Dronten 4
Las Vegas 4
Leawood 4
Monmouth Junction 4
Redmond 4
Riva 4
Tokyo 4
Andover 3
Ardabil 3
Augusta 3
Elora 3
Fremont 3
Kemerovo 3
Kostomloty Drugie 3
Lisbon 3
Manila 3
Naples 3
Redes 3
Riga 3
San Diego 3
Tappahannock 3
Victoria 3
Vienna 3
Yicheng 3
Ypsilanti 3
Bologna 2
Bratislava 2
Catanzaro 2
Jakarta 2
London 2
Madrid 2
Mit Ghamr 2
Moscow 2
New Delhi 2
Novokuznetsk 2
Phoenix 2
Totale 6.956
Nome #
Interferon-alpha-engineered Multipotent Mesenchymal Stromal Cells for the treatment of myeloma 163
Cell contact-dependent PMN HLA-DR and CD69 membrane expression induced by autologous mono-lymphocytes and cell lines. 151
Carrier protein-monensin conjugates: enhancement of immunotoxin cytotoxicity and potential in tumor treatment 130
Cytoreductive effects of anti-transferrin receptor immunotoxin in a multicellular tumor spheroid model 123
Escape mechanisms of human leukemic cells to long-term immunotoxin treatment in an in vitro experimental model 121
Human recombinant interleuki-4 inhibits lymphokine activated killer activity of sheep erythrocytes rosette-forming (E+) and -non-forming (E-) human lymphocytes 121
Blocking effect of human serum but not of cerebrospinal fluid on ricin A chain immunotoxin potentiation by monensin or carrier protein-monensin conjugates 119
Induction and expansion of an anti-tumor immune response by B7-1+ tumor cells in dependence on the anatomical site of delivery and the dose applied 118
Sensitivity of human leukemia cells in exponential or stationary growth phase to anti-CD5 immunotoxins. Role of intracellular processing events 117
Disposition of intrathecally administered immunotoxins in rats. A preliminary report 116
Induction of human immunodeficiency virus neutralizing antibodies using fusion complexes 115
Immunotoxins and other conjugates: preparation and general characteristics. 114
Prevention and monitoring of adverse events following immunization: the "Green Channel" of the Veneto region in Italy 113
Physiopatology of thymus involvment in myasthenia gravis 111
Problems and potentials in immunotoxin therapy 110
Anti-tumor effects of toxins targeted to the prostate specific membrane antigen. 109
Heterogeneity and modulation of tumor-associated antigens in human glioblastoma cell lines 106
A new case of reactive arthritis after hepatitis B vaccination [letter] [published erratum appears in Clin Exp Rheumatol 1993 Sep-Oct;11(5):585] 105
Autologous cellular vaccine allows control of cancer immunoediting in a mouse model of plasmacytoma. 105
The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumor cells by activating the MAPK pathways. 103
Mechanisms involved in serum-dependent inactivation of the immunotoxin enhancers monensin and carrier-protein-monensin 102
Human glioma cell lines: tumour associated antigens distribution and sensitivity to antibody-toxin or ligand-toxin conjugates. A preliminary report 102
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer 102
Overexpression of N-ras oncogene and epidermal growth factor receptor gene in human glioblastomas 101
Adhesion of immature and mature T cells induces in human thymic epithelial cells (TEC) activation of IL-6 gene trascription factors (NF-kappaB and NF-IL6) and IL-6 gene expression: role of alpha3beta1 and alpha6beta4 integrins. 101
Sensitivity of human glioma cells to cytotoxic heteroconjugates 100
Induction of HIV-1 neutralizing antibodies by fusion complexes 99
Analysis of CIITA encoding AIR-1 gene promoters in insulin-dependent diabetes mellitus and rheumatoid arthritis patients from the northeast of Italy: absence of sequence variability 99
In celiac disease a subset of autoantibodies against transglutaminase bind Toll like receptor 4 and induce activation of monocytes. 98
A comparative method for processing immunological parameters: developing an "Immunogram" 98
The puzzling uniqueness of the heterotrimeric G15 protein and its potential beyond hematopoiesis 98
Efficacy assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmacytoma model 97
Distribution of endocytosed molecules to intracellular acidic environments correlates with immunotoxin activity 94
Inducible and constitutive MHC class II gene expression. Distinct tissue-specific genetic controls. 94
HTLV type IIIB infection of human thymic epithelial cells: viral expression correlates with the induction of NF-kappa B-binding activity in cells activated by cell adhesion. 93
The "Green Channel" of the Veneto region as a model for vaccine safety monitoring in Italy. 92
Brain tumors. Biopathology and therapy 92
Immunotoxins synthesized with ricin and diphteria toxin: mechanism of action and improvement of their anti-tumor cell efficacy. 92
Reductive activation of ricin and ricin A-chain immunotoxins by protein disulfide isomerase and thioredoxin reductase. 91
Establishment and characterization of a new human melanoma cell line (HU 214) with a high growth potential and stable properties 91
Human MBP-specific T cells regulate IL-6 gene expression in astrocytes through cell-cell contacts and soluble factors 90
Analysis of mammalian scrapie protein by novel monoclonal antibodies recognizing distinct prion protein glycoforms: an immunoblot and immunohistochemical study at the light and electron microscopic levels. 90
Myasthenia gravis: immunohistological heterogeneity in microenvironmental organization of hyperplastic and neoplastic thymuses suggesting different mechanisms of tolerance breakdown 89
cellular proviral HIV-DNA decline and viral isolation in naive subjects with <5000 copies/ml of HIV-RNA and>500x10to the sixth/l CD4 cells treated with highly active antiretroviral therapy 89
Constitutive activation of p38 and ERK1/2 MAPKs in epithelial cells of myasthenic thymus leads to IL-6 and RANTES overexpression: effects on survival and migration of peripheral T and B cells. 88
Potentiation of cytotoxic heteroconjugates by monensin-carrier proteins 87
Thymocyte contact or monoclonal antibody-mediated clustering of 3beta1 or 6beta4 integrins activate interleukin-6 (IL-6) transcription factors (NF-kappaB and NF-IL6) and IL-6 production in human thymic epithelial cells. 87
Lymphocyte interactions in the presence of mitogens. New possibilities of exploring histocompatibility in the mouse and man 86
A non-parametric method for the analysis of experimental tumour growth data 86
A dominant linear B-cell epitope of ricin A-chain is the target of a neutralizing antibody response in Hodgkin's lymphoma patients treated with an anti-CD25 immunotoxin 86
IFN-γ induced by PHA stimulation as new marker for GVHD prediction in patients undergoing Allogeneic Hematopoietic Stem Cell Transplantation 85
Self-potentiation of ligand-toxin conjugates containing ricin A chain fused with viral structures 85
In vitro studies of HIV-1 infection in thymic lymphocytes: a putative role of the thymus in AIDS pathogenesis 84
Novel prion protein conformation and glycotype in Creutzfeldt-Jakob disease 84
Brentuximab vedotin: axonal microtubule's Apollyon 84
Expression of myelin basic protein (MBP) epitopes in human non-neural cells revealed by two anti-MBP IgM monoclonal antibodies 81
Evidence for a trans-acting activator function regulating the expression of the human CD5 antigen. 81
Consultancy and surveillance of post-immunization adverse events in the Veneto region of Italy for 1992-2008 81
Identification of Ricin A chain HLA II-restricted epitopes by human T-cell clones. 80
Celiac disease: a subset of autoantibodies against transglutaminases bind toll like receptor 4 and induced activation of monocytes 80
Study of platelet adhesion in patients with uncomplicated hypertension. 79
Immune regulation by Mesenchymal Stem Cells derived from adult spleen and thymus. 79
The detection of breast cancer (b.c.) cells in bone marrow (b.m.): comparative analysis of sensitivity and specificity of three different methods. 78
Lymphoid adhesion promotes human thymic epithelial cell survival via NF-(kappa)B activation. 77
Differential response of human basophil activation markers: a multi-parameter flow cytometry approach. 76
IL-6 gene expression in human astrocytes is enhanced after adhesion to MBP-specific T-cells: role of beta1 integrin and IFN-gamma in the induction of NF-kB and IRF-1 binding activity 75
Specific immune response to occupational antigens in asymptomatic egg processing workers. 75
Pharmacokinetics of intrathecal transferrin-ricin A chain immunotoxins 73
Heterogeneous response of individual multicellular tumour spheroids to immunotoxins and ricin toxin 73
[Immunopathological bases and clinical considerations on the primary immunological deficiencies] 73
Immunocytochemical characterization of long-term medulloblastoma cultures: preliminary report 72
Comparative analysis of three different methods in detecting breast cells in bone marrow. 72
Cytotoxic heteroconjugates for selective killing of target tumour cells. 72
Monitoring of cellular immunity by interferon gamma (IFN-g) Enzyme-Linked Immunosorbent Spot (ELISPOT) assay in kidney allograft recipients: preliminary results of a longitudinal study. 71
null 70
On the growth of dynamics of multicellular tumor spheroids : a preliminary report 69
HIV 1: origine e struttura 69
In vitro analysis of BCNU-sensitivity in human malignant gliomas. II. Cross-resistance studies with cisplatinum and nitrosoureas 68
Comparative analysis of three different techniques in detecting breast cancer (b.c.) cells in bone marrow (b.m.). 68
A six-color polychromatic flow cytometry to evaluate human basophil activation 68
Il ruolo dell'analisi del DNA mediante citometria a flusso nell'identificare i flasi positivi citologici da flogosi 67
Toxin conjugates for killing of brain tumor cells in vitro. 67
Valore diagnostico e prognostico delle analisi di laboratorio specifiche per l'infezione da HIV 1. 67
Changes of human B and B-1a peripheral blood lymphocytes with age. 66
Vaccine adverse event monitoring systems across the European Union countries: Time for unifying efforts 66
I tests di chemiosensibilità in vitro nei tumori cerebrali umani. [In vitro drug sensitivity tests in human brain tumors] 62
Caratterizzazione fenotipica di cloni ottenuti da una linea cellulare di melanoma umano. 62
Viable Newcastle Disease vaccine strains in a pharmaceutical dump 62
Modulation of antigen expression in a new human melanoma cell line with a high growth potential and stable properties. 61
HLA-DBQ1 typing of north east italian IDDM patients using amplified DNA oligonucleotide probes and a rapid DNA-enzyme immunoassay(DEIA). 60
null 60
Pharmacokinetics of intrathecal transferrin-ricin A chain immunotoxin 60
Modulation of tumor associated antigens in a new human melanoma cell line. 60
The complex interplay of the DQB1 and DQA1 loci in the generation of the susceptible and protective phenotype for insulin-dependent diabetes mellitus 59
In vitro analysis of BCNU-sensitivity in human malignant gliomas. I. A model study with alkylating, cross-linking and carbamoylating agents in anaplastic astrocytomas of pediatric age 58
Cellular proviral HIV-DNA decline and viral isolation in naïve subjects with <5000 copies/ml of HIV-RNA and >500 x 10(6)/l CD4 cells treated with highly active antiretroviral therapy. 58
Un metodo comparativo ed integrato per lo studio dei sistemi complessi 58
Oscillating growth patterns of multicellular tumour spheroids 57
Forecasting the growth of multicell tumour spheroids: implications for the dynamic growth of solid tumours. 57
Constitutive expression of CD69 in interspecies T-cell hybrids and locus assignment to human chromosome 12 57
Totale 8.690
Categoria #
all - tutte 28.624
article - articoli 22.959
book - libri 258
conference - conferenze 3.598
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.809
Totale 57.248


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.114 0 0 0 121 117 166 148 151 56 128 45 182
2020/20211.015 92 164 49 69 115 135 10 102 87 3 158 31
2021/20221.060 99 360 6 79 35 25 38 68 36 26 105 183
2022/20231.870 138 210 173 307 213 432 32 116 175 6 38 30
2023/2024821 46 60 71 144 90 141 27 45 8 34 104 51
2024/2025332 138 134 52 8 0 0 0 0 0 0 0 0
Totale 9.230